| Company* (Country;Symbol) |
Company | Type/Product Area | Terms/Details (Date) |
| ImaRx Therapeutics Inc. (IMRX) | Royal Philips Electronics | Research collaboration to evaluate Philips' ultrasound technology as part of ImaRx's SonoLysis program to develop new treatment for acute ischemic stroke | Philips Medical Systems division will provide ultrasound devices and technical assistance to ImaRx during laboratory and preclinical studies (11/5) |
| Urigen Pharmaceuticals Inc. (OTC BB:URGP) | Hyaluron Contract Manufacturing Inc. | Partnership to develop URG101, Urigen's fixed-dose combination of FDA-approved drugs targeting painful bladder syndrome | Further details were not disclosed (12/5) |
|
Notes: * Private companies are indicated with an asterisk. Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market. | |||
To read more on related topics, click on one of the words below.